What are the differences between herpes simplex virus type 1 (HSV‑1) and herpes simplex virus type 2 (HSV‑2)?

Key Differences Between HSV-1 and HSV-2

HSV-1 primarily causes oral infections and establishes latency in cervical ganglia, while HSV-2 predominantly causes genital infections and establishes latency in sacral ganglia, though both viruses can infect either anatomical site. 1, 2

Anatomical Distribution and Transmission

Primary Sites of Infection

• HSV-1 traditionally manifests above the neck (oropharynx, mouth, lips, chin) and is typically acquired in childhood through close contact 2
• HSV-2 nearly exclusively causes genital disease and is sexually transmitted 1
• Important caveat: HSV-1 is an increasing cause of first-episode genital herpes, particularly in well-resourced settings, through orogenital sexual practices 1, 2
• Both viruses can infect eyes, oropharynx, rectal mucosa, and other body sites including lower extremities 1, 2

Epidemiology

• HSV-1 seroprevalence: Approximately 47.8% of US population aged 14-49 years 1
• HSV-2 seroprevalence: 12.1% of US population aged 14-49 years 1
• Globally in 2020: 519.5 million people had prevalent HSV-2 infections (13.3%) and 376.2 million had prevalent genital HSV-1 infections (10.2%) 3

Neurological Latency Patterns

Ganglionic Differences

• HSV-1 preferentially establishes latency in cervical ganglia after oral infection and demonstrates preference for A5-positive neurons 1, 4
• HSV-2 establishes latency in sacral ganglia after genital infection and demonstrates preference for KH10-positive neurons 1, 4
• This neuronal subtype preference is influenced by the latency-associated transcript (LAT) regions specific to each virus type 4

Reactivation Characteristics

• HSV-1 shows higher frequency of latent infection in trigeminal ganglia after intranasal inoculation 5
• HSV-2 demonstrates higher frequency of latent infection in lumbosacral ganglia after intravaginal inoculation 5
• Both viruses reactivate at variable frequencies (once every few years to several times per month) 1

Clinical Manifestations

Primary Infection Severity

• HSV-1 primary infection: Children may develop severe oropharyngitis; if acquired as genital infection in adulthood without prior HSV-1 exposure, can cause severe genital lesions 1
• HSV-2 primary infection: Typically causes severe genital lesions in HSV-seronegative individuals 1
• Initial non-primary infection: When someone with HSV-1 antibodies acquires HSV-2 genitally, the infection is less severe but still recurs 1
• Incubation period for both: 2-10 days (up to 4 weeks) 1

Recurrence Patterns

• Both viruses cause recurrent infections at the same anatomical site as primary infection 1
• Episodes last less than 10 days unless complicated by secondary bacterial infection or immunosuppression 1
• 80-90% of genital herpes cases progress subclinically but may become symptomatic at any time 1

Virological and Molecular Differences

Cellular Interactions

• HSV-2 demonstrates enhanced capacity to enter and replicate in the central nervous system compared to HSV-1 5
• HSV-2 causes higher death rates in animal models across multiple routes of infection (intravaginal, intranasal, intraperitoneal, intracerebral) 5
• HSV-1 replicates to higher titers in vaginal mucosa despite HSV-2 causing higher mortality 5

Receptor Binding

• Both viruses use heparan sulfate (HS) as initial receptor, but recognize different structural features 6
• HSV-1 requires 6-O sulfations and 2-,3-O sulfations for optimal binding 6
• HSV-2 binding is less dependent on O-sulfations 6
• These differences are mediated by glycoprotein C variants (gC-1 vs gC-2) 6

Antigenic Differences

• Glycoprotein G (gG) contains the most type-specific antigenic determinants, with gG-1 and gG-2 having relatively long type-unique amino acid stretches 7
• Type-specific serology relies on these antigenic differences for diagnostic discrimination 7

Diagnostic Implications

Laboratory Testing

• Type-specific molecular or virologic tests should be used when genital ulcers are present 1
• Type-specific serologic tests detect antibody when lesions are absent 1
• Only 13% of HSV-2-seropositive persons have been diagnosed with genital herpes, indicating substantial underdiagnosis 1

Clinical Significance

HIV Interaction

• HSV-2 infection confers 3-fold increased risk of HIV acquisition compared to those without HSV-2 1

Neonatal Risk

• Both viruses can cause neonatal herpes (including neonatal encephalitis) when present in genital tract during delivery 1

Disease Burden

• In 2020, an estimated 187.9 million people aged 15-49 years had at least one episode of HSV-2-attributable genital ulcer disease 3
• An additional 16.7 million had HSV-1-attributable genital ulcer disease 3